These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6418888)

  • 21. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors.
    Shippenberg TS
    Neurosci Lett; 1991 Jan; 121(1-2):136-8. PubMed ID: 1826942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
    Svensson K; Hjorth S; Clark D; Carlsson A; Wikström H; Andersson B; Sanchez D; Johansson AM; Arvidsson LE; Hacksell U
    J Neural Transm; 1986; 65(1):1-27. PubMed ID: 3083041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats.
    Svensson K; Carlsson M; Carlsson A; Hjorth S; Johansson AM; Eriksson E
    Eur J Pharmacol; 1986 Nov; 130(3):237-42. PubMed ID: 3792447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin.
    Wikström H; Elebring T; Hallnemo G; Andersson B; Svensson K; Carlsson A; Rollema H
    J Med Chem; 1988 Jun; 31(6):1080-4. PubMed ID: 2967374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
    J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT.
    Emerit MB; Gozlan H; Marquet A; Hamon M
    Eur J Pharmacol; 1986 Aug; 127(1-2):67-81. PubMed ID: 2944752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivatives of 2-(dipropylamino)tetralin: effect of the C8-substituent on the interaction with 5-HT1A receptors.
    Liu Y; Yu H; Svensson BE; Cortizo L; Lewander T; Hacksell U
    J Med Chem; 1993 Dec; 36(26):4221-9. PubMed ID: 7506312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Lindberg P; Andersson B
    J Med Chem; 1988 Jan; 31(1):92-9. PubMed ID: 3336037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K; Johansson AM; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
    Glennon RA; Titeler M; Lyon RA; Slusher RM
    J Med Chem; 1988 Apr; 31(4):867-70. PubMed ID: 2965244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
    J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
    Johansson AM; Nilsson JL; Karlén A; Hacksell U; Sanchez D; Svensson K; Hjorth S; Carlsson A; Sundell S; Kenne L
    J Med Chem; 1987 Oct; 30(10):1827-37. PubMed ID: 3656358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine.
    Berge OG; Fasmer OB; Ogren SO; Hole K
    Neurosci Lett; 1985 Feb; 54(1):71-5. PubMed ID: 3156286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
    Tricklebank MD; Forler C; Fozard JR
    Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.